Preoperative therapy with trastuzumab and oral vinorelbine (± endocrine therapy) in patients with HER2-positive breast cancer-Reference-Cited by-同舟云学术

Preoperative therapy with trastuzumab and oral vinorelbine (± endocrine therapy) in patients with HER2-positive breast cancer

Published:2010-04 Issue:2 Volume:19 Page:128-132
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Iorfida Monica,Bagnardi Vincenzo,Balduzzi Alessandra,Dellapasqua Silvia,Cardillo Anna,Luini Alberto,Intra Mattia,Minchella Ida,Veronesi Paolo,Viale Giuseppe,Goldhirsch Aron,Colleoni Marco

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference33 articles.

1. Integrating trastuzumab in the neoadjuvant treatment of primary breast cancer: accumulating evidence of efficacy, synergy and safety;Lazaridis;Crit Rev Oncol Hematol,2008

2. A review of the use of trastuzumab (Herceptin®) plus vinorelbine in metastatic breast cancer;Chan;Ann Oncol,2007

3. Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane Study;Burstein;Cancer,2007

4. Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer;Harris;Clin Cancer Res,2007

5. Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancer;Bartsch;Breast Cancer Res Treat,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial;European Journal of Cancer;2021-03

2. Activity and resistance of trastuzumab according to different clinical settings;Cancer Treatment Reviews;2012-05

3. The HER2 World: Better Treatment Selection for Better Outcome;JNCI Monographs;2011-10-01

4. Current World Literature;Current Opinion in Obstetrics & Gynecology;2011-02

5. Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer;Breast Cancer Research and Treatment;2011-01-08